AMBROS PHARMA S R L has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in Italy, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are L T T KENKYUSHO KK, MEDPROJECT PHARMA ENTW UND VERTRIEBSGESELLSCHAFT MBH and GRIMBERG GEORGES SERGE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 9 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Surface technology and coating | |
#6 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Medical purpose containers | |
#5 | Specific use of cosmetics | |
#6 | Layered products | |
#7 | Doors and windows |
# | Name | Total Patents |
---|---|---|
#1 | Stankov Bojidar Mihaylov | 11 |
#2 | Stankov Bojidar M | 7 |
#3 | Costa Andrea | 1 |
Publication | Filing date | Title |
---|---|---|
US2017165232A1 | Three-phase controlled-release tablet comprising melatonin and process of preparation | |
EP2598124A1 | Three-phase controlled-release tablet comprising melatonin and process of preparation | |
WO2011077406A2 | Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan | |
US2008187587A1 | Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation | |
US2006045913A1 | Controlled-release formulations containing tryptophan or its metabolites | |
US6447818B1 | Compositions containing compounds with adrenergic activity and vegetable extracts of Crataegus and gingko biloba for the treatment of overweight and obesity |